I realize that tolerance quickly builds to phenibut's sedative effects, but maybe we are wrong in thinking it tolerance builds to all of its effects.
http://onlinelibrary...1.tb00211.x/pdf
on page 4 suggests
Chronic administration of PB (50 mg kg i.p., twice daily for 5 days) promoted a tolerance to its sedative action on the last day of treatment while its nootropic effect was enhanced.
(the dosage here would be about 570mg in humans if injected. The bioavailability may not be good for phenibut orally, so the dosage would have to be adjusted accordingly)
and on page 5,
Discontinuation of chronic injections of PB to rats increases the density of GABA A and BDZ receptors in striatum while that of GABA B is decreased (38). Chronically administered BDZs have opposite effects.
would suggest that phenibut both Increases GABA-B receptor sites (while also binding to them) and decreases sensitivity of GABA-A (since the opposite of those happen on discontinuation). The wording is a bit odd, though, and the next sentence claims that "Chronically administered BDZs have opposite effects". I assume they mean the administration has the opposite effects from the discontinuation of phenibut? That is strange wording, but BDZs decrease GABA-A sensitivity with chronic use, right?
The difference between the two, though, is that phenibut possesses action at GABA-B receptors which would become more sensitive over time as the GABA-A receptors return to homeostasis.
Chronic i.p. administration of PB in mice antagonized the development of morphine dependence (5,6). BAC and sodium valproate had similar effects. PB also reduced naloxone-induced withdrawal effects in mice addicted to morphine (6).
on page 5 is also in line with the theory that GABA-B receptor action remains or increases with chronic use since GABA-B receptor agonists are known for decreasing drug dependence.
So, I think it is possible that phenibut possesses actual nootropic effects that we are overlooking by using it as a sedative. Although a crappy sedative due to swift tolerance, it could end up being a nice cognition/mood enhancer by acting on GABA-B receptors once the GABA-A receptors have downregulated to a homeostatic level.
I know it is only one paper, but do you think it is possible that phenibut exhibits nootropic effects through GABA-B receptors, and the initial effects that most people chase are only the effects on GABA-A receptors?